Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Intra-Cellular Therapies, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 266 | 274 | +8 |
| Shares | 81.5M | 83.5M | +2.01M (+2.5%) |
| Value | $4.65B | $3.89B | −$766.5M (−16.5%) |
New holders (43)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (35)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.